CPG (code) | AGREE-II domains | Quality of the systematic reviews (Yes or No) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | Overall assessment | Mentions databases used | Mentions search strategy | List of included studies is available | Mentioned risk of bias assessment as part of their methodology | |
Canadian Network for Mood and Anxiety Treatments (CANMAT) | 92% | 67% | 53% | 83% | 0% | 100% | 67% | 66% | Yes | Yes | No | No |
Depression Guideline Development Group (WHO) | 100% | 67% | 48% | 89% | 38% | 8% | 50% | 57% | Yes | No | No | No |
National Collaborating Centre for Mental Health, National Institute for Health and Clinical Excellence (NICE) | 100% | 100% | 85% | 100% | 40% | 100% | 83% | 87% | Yes | Yes | Yes | Yes |
Agencia de Evaluación de TecnologÃas Sanitarias de Galicia (GuiaSalud) | 100% | 92% | 60% | 94% | 96% | 100% | 67% | 87% | Yes | No | Yes | Yes |
American College of Physicians (ACP) | 100% | 89% | 88% | 72% | 0% | 100% | 83% | 76% | Yes | Yes | Yes | Yes |
American Psychiatric Association (APA) | 94% | 64% | 55% | 89% | 15% | 100% | 67% | 67% | Yes | No | No | No |
Royal Australian and New Zealand College of Psychiatrists (RANZCP) | 100% | 81% | 59% | 100% | 8% | 100% | 67% | 74% | Yes | No | No | No |
US Preventive Services Task Force Recommendation Statement (USTF) | 94% | 53% | 65% | 86% | 17% | 100% | 83% | 71% | Yes | Yes | Yes | Yes |
Management of Major Depressive Disorder Working Group (VADoD) | 94% | 86% | 78% | 100% | 17% | 100% | 83% | 80% | Yes | Yes | No | Yes |
Korean Guideline Development Team for Depression (Korea) | 75% | 47% | 45% | 78% | 4% | 83% | 42% | 53% | Yes | No | No | No |
British Association for Psychopharmacology (BAP) | 83% | 56% | 55% | 78% | 13% | 83% | 58% | 61% | Yes | No | No | Yes |